Observational studyAntimicrobial agents and chemotherapy2023

QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies.

Ali Mohamed Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.